£101.29

Academic Press Neuroinflammation, Resolution, and Neuroprotection in the Brain

Price data last checked 93 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 7 months ago.

£101 today · all-time low £98 (Oct 2025) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 493 days • 493 data points (No recent data available)

Historical
Generating forecast...
£102.13 £97.35 £98.39 £99.43 £100.48 £101.52 £102.57 02 November 2024 05 March 2025 06 July 2025 06 November 2025 09 March 2026

Price Distribution

Price distribution over 493 days • 5 price levels

Days at Price
Current Price
79 days 223 days 47 days 136 days · current 8 days 0 56 112 167 223 £98 £99 £100 £101 £102 Days at Price

Price Analysis

Most common price: £99 (223 days, 45.2%)

Price range: £98 - £102

Price levels: 5 different prices over 493 days

Description

Neuroinflammation, Resolution, and Neuroprotection in the Brain discusses the molecular aspects of neuroinflammation in neurological disorders. The book examines the effect of diet and exercise on neuroinflammatory diseases. Chapters focus on bioactive lipids, cytokines and chemokines, as well as the involvement of neuroinflammation, resolution and neuroprotection in neurotraumatic diseases, neurodegenerative diseases and neuropsychiatric diseases. The comprehensive information in this monograph will help readers understand molecular cross-talk among mediators of phospholipid, sphingolipid and cholesterol metabolism. The book's goal is to jumpstart more studies on molecular mechanisms and the therapeutic aspects of neurological disorders in human subjects. Review Presents a thorough review on the molecular aspects of neuroinflammation in neurological disorders, along with the effects of diet and exercise From the Back Cover Neuroinflammation, Resolution, and Neuroprotection in the Brain discusses the molecular aspects of neuroinflammation in neurological disorders. It also examines the effect of diet and exercise on neuroinflammatory diseases. Chapters focus on bioactive lipids, cytokines and chemokines, as well as the involvement of neuroinflammation, resolution and neuroprotection in neurotraumatic diseases, neurodegenerative diseases and neuropsychiatric diseases. The comprehensive information in this monograph may help in understanding molecular cross-talk among mediators of phospholipid, sphingolipid, and cholesterol metabolism. Levels of these mediators may help in early detection of various neurological disorders. The goal is that this may jumpstart more studies on molecular mechanisms and therapeutic aspects of neurological disorders in human subjects. About the Author Akhlaq A. Farooqui is a leader in the field of signal transduction processes, lipid mediators, phospholipases, glutamate neurotoxicity, and neurological disorders. He is a research scientist in the Department of Molecular and Cellular Biochemistry at The Ohio State University. He has published cutting edge research on the role of phospholipases A2 in signal transduction processes, generation and identification of lipid mediators during neurodegeneration by lipidomics. He has studied the involvement of glycerophospholipid, sphingolipid-, and cholesterol-derived lipid mediators in kainic acid neurotoxicity, an experimental model of neurodegenerative diseases. Akhlaq A. Farooqui has discovered the stimulation of plasmalogen- selective phospholipase A2 in brains of patients with Alzheimer disease (AD). Stimulation of this enzyme may not only be responsible for the deficiency of plasmalogens in neural membranes of AD patients, but also be related to the loss of synapse in the AD.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders
99% match

Molecular Aspects of Neurodegeneration, Neuroprotection, and Regeneration in Neurological Disorders

Academic Press

£101.89 26 Jan 2026
Beneficial Effects of Fish Oil on Human Brain
98% match

Beneficial Effects of Fish Oil on Human Brain

Springer

£135.10 27 Jan 2026
Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases
96% match

Neurochemical Aspects of Neurotraumatic and Neurodegenerative Diseases

Springer

£179.99 22 Jan 2026
Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP): 76 (Subcellular Biochemistry, 76)
95% match

Neuronal Tissue-Nonspecific Alkaline Phosphatase (TNAP): 76 (Subcellular Biochemistry, 76)

Springer

£140.38 09 Dec 2025
Quality Control of Cellular Protein in Neurodegenerative Disorders (Advances in Medical Diagnosis, Treatment, and Care)
95% match

Quality Control of Cellular Protein in Neurodegenerative Disorders (Advances in Medical Diagnosis, Treatment, and Care)

Medical Information Science Reference

£265.87 22 Jan 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
95% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£143.46 23 Jan 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
95% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£81.52 28 Feb 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
95% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Mar 2026
Springer - Glycerophospholipids in the Brain Book
95% match

Springer - Glycerophospholipids in the Brain Book

Springer

£36.00 19 Feb 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
95% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.24 09 Mar 2026
Lipid Mediators and Their Metabolism in the Brain
95% match

Lipid Mediators and Their Metabolism in the Brain

Springer

£146.40 28 Jan 2026
Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)
95% match

Brain Imaging: Volume 165 (Progress in Molecular Biology and Translational Science, Volume 165)

Academic Press

£114.49 10 Mar 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
95% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£67.65 11 Mar 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
95% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£24.24 24 Feb 2026
Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)
95% match

Molecular Biology of Neurodegenerative Diseases: Visions for the Future - Part B (Volume 177) (Progress in Molecular Biology and Translational Science, Volume 177)

Academic Press

£79.99 11 Mar 2026
Memory Loss, Alzheimer's Disease and Dementia: A Practical Guide for Clinicians
95% match

Memory Loss, Alzheimer's Disease and Dementia: A Practical Guide for Clinicians

Elsevier

£63.75 22 Jan 2026
Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases
95% match

Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases

Academic Press

£56.67 09 Apr 2026
Early Detection of Alzheimer’s Disease: Biological and Technological Advances
95% match

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

Academic Press

£102.26 10 Mar 2026
Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)
95% match

Cerebrospinal Fluid Biomarkers: 168 (Neuromethods, 168)

Humana

£135.88 21 Jan 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
94% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£13.02 28 Feb 2026
Pathobiology of Alzheimer's Disease (Neuroscience Perspectives)
94% match

Pathobiology of Alzheimer's Disease (Neuroscience Perspectives)

Academic Press

£102.40 10 Jan 2026
Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107
94% match

Molecular Biology of Neurodegenerative Diseases (Progress in Molecular Biology and Translational Science): Volume 107

Academic Press

£96.25 09 Mar 2026
Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)
94% match

Macro Roles for MicroRNAs in the Life and Death of Neurons (Research and Perspectives in Neurosciences)

Springer

£107.73 09 Apr 2026
Developmental Plasticity of Inhibitory Circuitry
94% match

Developmental Plasticity of Inhibitory Circuitry

Springer

£105.43 15 Apr 2026